Laurie Stelzer Insider Trading $GYHT HALOZYME THERAPEUTICS, INC.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Laurie Stelzer.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Laurie Stelzer. Laurie Stelzer is EVP & Chief Financial Officer in ARENA PHARMACEUTICALS INC ($ARNA) and Chief Financial Officer in HALOZYME THERAPEUTICS INC ($GYHT) and SVP, CFO in HALOZYME THERAPEUTICS INC ($GYHT) and SVP, Chief Financial Officer in HALOZYME THERAPEUTICS INC ($GYHT) and Director in PMV Pharmaceuticals, Inc. ($PMVP) and Director in Surface Oncology, Inc. ($SURF).

Laurie Stelzer in HALOZYME THERAPEUTICS, INC.

Trading Symbol: GYHT
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Laurie Stelzer: SVP, Chief Financial Officer, Chief Financial Officer, SVP, CFO
Holdings: 120,675 shares
Latest Transaction: Feb 24 2020

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Laurie Stelzer in HALOZYME THERAPEUTICS, INC.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ARNA, GYHT, PMVP, SURF

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Feb 24 2020GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...Option ExerciseM0.0011,392011,392
Feb 24 2020GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...Payment of ExerciseF21.834,50898,410116,167120.7 K to 116.2 K (-3.74 %)
Feb 24 2020GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...BuyM0.0011,3920120,675109.3 K to 120.7 K (+10.42 %)
Feb 13 2020GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...Option ExerciseM0.0011,26200
Feb 13 2020GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...Payment of ExerciseF20.003,89477,880104,174108.1 K to 104.2 K (-3.60 %)
Feb 13 2020GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...BuyM0.0011,2620108,06896.8 K to 108.1 K (+11.63 %)
Feb 12 2020GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...Option ExerciseA0.0032,533032,533
Feb 12 2020GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...Option ExerciseA19.9869,1741,382,09769,174
Feb 04 2020GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...Option ExerciseM0.0023,11900
Feb 04 2020GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...Payment of ExerciseF19.218,275158,96396,806105.1 K to 96.8 K (-7.87 %)
Feb 04 2020GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...BuyM0.0023,1190105,08182 K to 105.1 K (+28.21 %)
Jun 17 2019GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...Option ExerciseM0.006,87500
Jun 17 2019GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...Payment of ExerciseF15.733,40853,60881,96285.4 K to 82 K (-3.99 %)
Jun 17 2019GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...BuyM0.006,875085,37078.5 K to 85.4 K (+8.76 %)
Feb 22 2019GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...Option ExerciseM0.0011,392022,784
Feb 22 2019GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...Payment of ExerciseF16.813,93966,21578,49582.4 K to 78.5 K (-4.78 %)
Feb 22 2019GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...BuyM0.0011,392082,43471 K to 82.4 K (+16.04 %)
Feb 15 2019GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...Option ExerciseM0.007,809023,425
Feb 15 2019GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...Payment of ExerciseF16.542,70044,65871,04273.7 K to 71 K (-3.66 %)
Feb 15 2019GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...BuyM0.007,809073,74265.9 K to 73.7 K (+11.84 %)
Feb 14 2019GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...Option ExerciseA0.0045,046045,046
Feb 14 2019GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...Option ExerciseA16.6585,9221,430,60185,922
Feb 05 2019GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...Option ExerciseM0.0023,119023,119
Feb 05 2019GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...Payment of ExerciseF16.128,317134,07065,93374.3 K to 65.9 K (-11.20 %)
Feb 05 2019GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...BuyM0.0023,119074,25051.1 K to 74.3 K (+45.22 %)
Feb 23 2018GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...Option ExerciseM0.0011,392034,176
Feb 23 2018GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...Payment of ExerciseF19.283,93975,94447,51051.4 K to 47.5 K (-7.66 %)
Feb 23 2018GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...BuyM0.0011,392051,44940.1 K to 51.4 K (+28.44 %)
Feb 16 2018GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...Option ExerciseA0.0031,234031,234
Feb 16 2018GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...Option ExerciseA18.4154,7801,008,50054,780
Feb 05 2018GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...Option ExerciseM0.0023,120046,238
Feb 05 2018GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...Payment of ExerciseF18.378,265151,82840,05748.3 K to 40.1 K (-17.10 %)
Feb 05 2018GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...BuyM0.0023,120048,32225.2 K to 48.3 K (+91.74 %)
Jun 16 2017GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...Option ExerciseM0.006,875013,750
Jun 16 2017GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...Payment of ExerciseF13.052,58333,70825,20227.8 K to 25.2 K (-9.30 %)
Jun 16 2017GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...BuyM0.006,875027,78520.9 K to 27.8 K (+32.88 %)
Feb 24 2017GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...Option ExerciseA0.0045,568045,568
Feb 24 2017GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...Option ExerciseA12.0772,925880,20572,925
Feb 06 2017GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...Option ExerciseM0.0023,120069,358
Feb 06 2017GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...Payment of ExerciseF12.269,085111,38220,91030 K to 20.9 K (-30.29 %)
Feb 06 2017GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...BuyM0.0023,120029,9956.9 K to 30 K (+336.29 %)
Jun 16 2016GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...Option ExerciseM0.006,875020,625
Jun 16 2016GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...BuyM0.006,875016,87510 K to 16.9 K (+68.75 %)
Feb 04 2016GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...Option ExerciseA92,478.0092,4788,552,180,48492,478
Feb 04 2016GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...Option ExerciseA8.11104,603848,330104,603
Aug 24 2015GYHTHALOZYME THERAPEUT ...Stelzer LaurieChief Financial Off ...BuyP17.2410,000172,38410,0000 to 10 K
Jun 16 2015GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, CFOOption ExerciseA0.0027,500027,500
Jun 16 2015GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, CFOOption ExerciseA20.43225,0004,596,750225,000

Page:   1

Contact us | Follow us on Twitter